Skip to main content
Figure 1 | Infectious Agents and Cancer

Figure 1

From: Cervical human papillomavirus prevalence and genotype distribution among hybrid capture 2 positive women 15 to 64 years of age in the Gurage zone, rural Ethiopia

Figure 1

Flow diagram of sample processing. HPV screening by Hybrid Capture 2 HPV DNA Test, followed by β-Globin-PCR testing (not shown in figure) and high risk HPV genotyping of all HC2 HR positive samples by the Genotyping Kit HPV GP and subsequent testing by the SPF10-LiPA25 system, version 1, of all HC2 HR HPV positive samples, in which no HPV type was identified by the Genotyping Kit HPV GP. Square brackets show the number (%) of results in relation to the preceding assay performed.

Back to article page